<DOC>
	<DOC>NCT00713258</DOC>
	<brief_summary>The primary objective of this trial is to show that PTH(1-84) is superior to alendronate in reducing back pain intensity over a 24-week treatment period in postmenopausal women with an osteoporosis related vertebral fracture(s). Secondly the objectives are to investigate any differences in patient reported outcomes between the two treatment arms over a 24-week treatment period in postmenopausal women with an osteoporosis related vertebral fracture(s).</brief_summary>
	<brief_title>The Effect of PTH(1-84) or Alendronate on Reduction of Back Pain in Postmenopausal Women With an Osteoporosis Related Vertebral Fracture(s) (FP-005-IM)</brief_title>
	<detailed_description />
	<mesh_term>Back Pain</mesh_term>
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Spinal Fractures</mesh_term>
	<mesh_term>Fractures, Bone</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<mesh_term>Alendronate</mesh_term>
	<criteria>Postmenopausal women with a Tscore â‰¤ 1.5 SD and at least one osteoporosis related vertebral fracture. Chronic back pain. Previous/current treatment and medical history.</criteria>
	<gender>Female</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>Postmenopausal women</keyword>
	<keyword>Back pain</keyword>
	<keyword>Osteoporosis related fracture</keyword>
</DOC>